Xeris Pharmaceuticals | XERS - 营业费用



金融业
股票价格
USD
资产
USD 411.91M
现金及等价物
USD 121.75M
销售成本
USD 10.57M
流动资产
USD 274.76M
流动负债
USD 189.57M
债务
USD 258.55M
EBIT
USD 9.12M
EBITDA
USD 12.33M
员工
377
EPS每股收益
USD 0.01
股本和储备
USD -9.73M
销售毛利
USD 72.55M
债务利息支出
USD 6.88M
利息收入
USD 1.2M
贷款资金
USD 188.81M
市值
USD 1.19B
净收入
USD 2.23M
营业费用
USD 75.21M
营业利润
USD 7.92M
普通股股本
USD 172.56M
PE价格收益
76.05
税前利润
USD 2.23M
销售收入
USD 83.13M
销售和管理费用
USD 53.14M
股票
USD 80.93M
贸易债权人
USD 9.34M
应收帐款人
USD 56.3M


营业费用 更改 日
Celltrion KRW 119.22B 21.46B 2026-03
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 173K 990K 2025-12
Pacira USD 180.54M 7.79M 2026-06
Perrigo USD 290.5M 645.1M 2026-06
Pharma Mar EUR 51.01M 8.73M 2026-06
Qiagen NV USD 393.64M 17.95M 2026-06
Sartorius EUR 747.8M 9.4M 2026-06
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Tilray USD 237.52M 17.34M 2025-09
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.45B 431.06M 2026-06